News | April 02, 2025
Emcutix and WiQo sign licensing partnership for derma-cosmetic treatments in India
PRX-PLUS has a unique product feature with its deep-impacting formula
PRX-PLUS has a unique product feature with its deep-impacting formula
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
The first-of-its-kind study will evaluate potential association between GSK’s shingles vaccine and reduced dementia risk, building on growing body of evidence from observational and retrospective studies
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific
Encourages working women to practice self-care
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
